U.S. Markets open in 3 hrs 34 mins

Questcor weakness a buying opporunity, says Roth Capital

Roth Capital said Questcor (QCOR) has no added risk from Aetna's (AET) clinical policy bulletin update and recommends using weakness as a buying opportunity. Shares are Buy rated.